Our read is that taking Coenzyme Q10 is well supported for its role in mitochondrial health and fertility, particularly for those with deficiencies or on statins.
Our read is that CoQ10 is a critical nutrient supporting mitochondrial health, which is vital for various bodily functions, including egg and sperm formation and fertilization.
Deficiencies in CoQ10 can lead to noticeable impairments in mitochondrial circuitry, impacting mood, energy, bone mineralization, and cardiovascular health.
While some forms have poor bioavailability, consistent adherence to supplementation, often alongside dietary changes, is key for efficacy.
A daily dosage of 100 to 400 milligrams of CoQ10, taken with a meal containing fat, is commonly suggested for improving fertility in both men and women. For individuals on statins, increasing intake of organ meats and muscle meat is advised to compensate for reduced CoQ10 production. The most important factor for supplement efficacy is consistent adherence, meaning the form of CoQ10 that is taken consistently is the better form.
Paul Saladino suggested that some studies on CoQ10 and statins may be flawed due to low doses, unmeasured CoQ10 levels, and short duration. He also noted that consuming a kilogram of soybean oil for CoQ10 is impractical and potentially harmful due to high linoleic acid content. Peter Attia does not object to patients taking Coenzyme Q10 or Vitamin D for statin-associated muscle symptoms if it improves adherence, but also stated that most antioxidants, including CoQ10, offer minimal benefit and minimal harm. Rhonda Patrick indicated that ubiquinol supplementation has not been shown in clinical trials to reduce statin-induced muscle soreness, though some patients report feeling better. Paul Saladino mentioned that vegan CoQ10 may not be comparable in form or bioavailability to animal-derived CoQ10. Peter Attia and Andrew Huberman both noted that Coenzyme Q10 (ubiquinol) is an antioxidant with poor bioavailability in most available preparations. Rhonda Patrick stated it is not clear if ubiquinol offsets mitochondrial dysfunction in patients taking statins. Andrew Huberman noted CoQ10 is generally stopped during pregnancy due to a lack of data.
New clinical trials demonstrating clear efficacy or lack thereof for specific conditions, or improved bioavailability formulations, would change the verdict. Further research clarifying the impact of CoQ10 on statin-induced muscle soreness and mitochondrial dysfunction would also be impactful.
The effect size is large enough to matter clinically, not just statistically.
Benefits hold across the populations where it's been tested.
Benefits hold across the populations where it's been tested.
The effect size is large enough to matter clinically, not just statistically.
Mechanistic and trial evidence converge on a real, replicable effect.
Animal-model results don't translate to the human protocol being recommended.
The headline effect shrinks once you account for trial quality.
The headline effect shrinks once you account for trial quality.
The headline effect shrinks once you account for trial quality.
Animal-model results don't translate to the human protocol being recommended.